![Nicole LASSERRE LASO | Professor (Assistant) | MSc. Human Nutrition | University Santo Tomás (Chile), Santiago | UST | Research profile Nicole LASSERRE LASO | Professor (Assistant) | MSc. Human Nutrition | University Santo Tomás (Chile), Santiago | UST | Research profile](https://i1.rgstatic.net/ii/profile.image/755624182820866-1557166252232_Q512/Nicole-Lasserre-Laso.jpg)
Nicole LASSERRE LASO | Professor (Assistant) | MSc. Human Nutrition | University Santo Tomás (Chile), Santiago | UST | Research profile
![United States: Fresenius Kabi achieves global agreement with AbbVie with respect to Fresenius adalimumab, a biosimilar candidate of AbbVie Humira - OlarteMoure | Intellectual Property United States: Fresenius Kabi achieves global agreement with AbbVie with respect to Fresenius adalimumab, a biosimilar candidate of AbbVie Humira - OlarteMoure | Intellectual Property](https://www.olartemoure.com/wp-content/uploads/2018/10/3.jpg)
United States: Fresenius Kabi achieves global agreement with AbbVie with respect to Fresenius adalimumab, a biosimilar candidate of AbbVie Humira - OlarteMoure | Intellectual Property
![LOS EXPERTOS OPINAN: ESPECIAL COVID-19 (Eugenio-Pacelli Lanzas Martín, Laso & Asociados) - Multimedia - Observatorio Inmobiliario LOS EXPERTOS OPINAN: ESPECIAL COVID-19 (Eugenio-Pacelli Lanzas Martín, Laso & Asociados) - Multimedia - Observatorio Inmobiliario](https://i.ytimg.com/vi/rFTYNwza2PY/maxresdefault.jpg)